{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:42:08Z","timestamp":1779345728133,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6835","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2001,5,17]]},"DOI":"10.1038\/35077241","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:43:34Z","timestamp":1027673014000},"page":"375-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1852,"title":["The microenvironment of the tumour\u2013host interface"],"prefix":"10.1038","volume":"411","author":[{"given":"Lance A.","family":"Liotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elise C.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,5,1]]},"reference":[{"key":"BF35077241_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"BF35077241_CR2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S1357-4310(00)01756-1","volume":"6","author":"CC Park","year":"2000","unstructured":"Park, C. C., Bissell, M. J. & Barcellos-Hoff, M. H. The influence of the microenvironment on the malignant phenotype. Mol. Med. Today 6, 324\u2013329 (2000).","journal-title":"Mol. Med. Today"},{"key":"BF35077241_CR3","first-page":"1041","volume":"5","author":"LF Brown","year":"1999","unstructured":"Brown, L. F. et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin. Cancer Res. 5, 1041\u20131056 (1999).","journal-title":"Clin. Cancer Res."},{"key":"BF35077241_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s004280050053","volume":"430","author":"N Wernert","year":"1997","unstructured":"Wernert, N. The multiple roles of tumor stroma. Virchows Arch. 430, 433\u2013443 (1997).","journal-title":"Virchows Arch."},{"key":"BF35077241_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1432-0436.1999.6520113.x","volume":"65","author":"S Aboseif","year":"1999","unstructured":"Aboseif, S., El-Sakka, A., Young, P. & Cunha, G. Mesenchymal reprogramming of adult human epithelial differentiation. Differentiation 65, 113\u2013118 (1999).","journal-title":"Differentiation"},{"key":"BF35077241_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1523-1747.1999.00701.x","volume":"113","author":"M Vaccariello","year":"1999","unstructured":"Vaccariello, M., Javaherian, A., Wang, Y., Fusenig, N. E. & Garlick, J. A. Cell interactions control the fate of malignant keratinocytes in an organitypic model of early neoplasia. J. Invest. Dermatol. 113, 384\u2013391 (1999).","journal-title":"J. Invest. Dermatol."},{"key":"BF35077241_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s002800051091","volume":"43","author":"I Fidler","year":"1999","unstructured":"Fidler, I. Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother. Pharmacol. 43, 3\u201310 (1999).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BF35077241_CR8","doi-asserted-by":"crossref","unstructured":"Nilsson, E. & Skinner, M. K. Cellular interactions that control primordial follicle development and folliculogenesis. J. Soc. Gynecol. Invest. 8, S17\u2013S20 (2001).","DOI":"10.1177\/1071557601008001S06"},{"key":"BF35077241_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1432-0436.2000.660207.x","volume":"66","author":"Y Li","year":"2000","unstructured":"Li, Y., Liu, W., Hayward, S. W., Cunha, G. & Baskin, L. S. Plasticity of the urothelial phenotype: effects of gastro-intestinal mesenchyme\/stroma and implications for urinary tract reconstruction. Differentiation 66, 126\u2013135 (2000).","journal-title":"Differentiation"},{"key":"BF35077241_CR10","first-page":"5002","volume":"59","author":"AF Olumi","year":"1999","unstructured":"Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002\u20135011 (1999).","journal-title":"Cancer Res."},{"key":"BF35077241_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","volume":"64","author":"LA Liotta","year":"1991","unstructured":"Liotta, L. A., Steeg, P. S. & Stetler-Stevension, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64, 327 (1991).","journal-title":"Cell"},{"key":"BF35077241_CR12","first-page":"1856","volume":"55","author":"EC Kohn","year":"1995","unstructured":"Kohn, E. C. & Liotta, L. A. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 55, 1856\u20131862 (1995).","journal-title":"Cancer Res."},{"key":"BF35077241_CR13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1074-5521(96)90176-3","volume":"3","author":"S Stromblad","year":"1996","unstructured":"Stromblad, S. & Cheresh, D. A. Integrins, angiogenesis and vascular cell survival. Chem. Biol. 3, 881\u2013885 (1996).","journal-title":"Chem. Biol."},{"key":"BF35077241_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249\u20132571 (2000).","journal-title":"Nature"},{"key":"BF35077241_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1046\/j.1432-0436.1999.6450263.x","volume":"64","author":"P Tomakidi","year":"1999","unstructured":"Tomakidi, P. et al. Defects in the basement membrane and hemidesmisomes structure correlate with malignant phenotype and stromal interactions in HaCaT-Ras xenografts. Differentiation 64, 263\u2013275 (1999).","journal-title":"Differentiation"},{"key":"BF35077241_CR16","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y","volume":"80","author":"AJ Guidi","year":"1997","unstructured":"Guidi, A. J. et al. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 80, 1945\u20131953 (1997).","journal-title":"Cancer"},{"key":"BF35077241_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<285::AID-PATH238>3.0.CO;2-R","volume":"187","author":"AH Lee","year":"1999","unstructured":"Lee, A. H., Dublin, E. A. & Bobrow, L. G. Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast. J. Pathol. 187, 285\u2013290 (1999).","journal-title":"J. Pathol."},{"key":"BF35077241_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.neo.7900032","volume":"1","author":"A Gilead","year":"1999","unstructured":"Gilead, A. & Neeman, M. Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. Neoplasia 1, 226\u2013230 (1999).","journal-title":"Neoplasia"},{"key":"BF35077241_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1046\/j.1523-1747.2001.00223.x","volume":"116","author":"K Airola","year":"2000","unstructured":"Airola, K. & Fusenig, N. E. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. J. Invest. Dermatol. 116, 85\u201392 (2000).","journal-title":"J. Invest. Dermatol."},{"key":"BF35077241_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(00)81009-0","volume":"98","author":"MD Sternlicht","year":"1999","unstructured":"Sternlicht, M. D. et al. The stromal proteinase MMP-3\/stromelysin-1 promotes mammary carcinogenesis. Cell 98, 137\u2013146 (1999).","journal-title":"Cell"},{"key":"BF35077241_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/71429","volume":"6","author":"A Mehdi","year":"2000","unstructured":"Mehdi, A. et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nature Med. 6, 100\u2013106 (2000).","journal-title":"Nature Med."},{"key":"BF35077241_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0092-8674(00)80429-8","volume":"91","author":"Z Werb","year":"1997","unstructured":"Werb, Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91, 439\u2013442 (1997).","journal-title":"Cell"},{"key":"BF35077241_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)00139-2","volume":"103","author":"LM Coussens","year":"2000","unstructured":"Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481\u2013490 (2000).","journal-title":"Cell"},{"key":"BF35077241_CR24","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1038\/sj.onc.1202827","volume":"18","author":"E Bowden","year":"1999","unstructured":"Bowden, E., Barth, M., Thomas, D., Glazer, R. & Mueller, S. An invasion related complex of cortactin, paxillin, and PKC\u03bc associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18, 4440\u20134449 (1999).","journal-title":"Oncogene"},{"key":"BF35077241_CR25","doi-asserted-by":"publisher","first-page":"7959","DOI":"10.1073\/pnas.94.15.7959","volume":"94","author":"H Nakahara","year":"1997","unstructured":"Nakahara, H. et al. Transmembrane\/cytoplasmic domain mediated membrane type 1-matrix metalloproteinase docking to invadopodia is required for cell invasion. Proc. Natl Acad. Sci. USA 94, 7959\u20137964 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35077241_CR26","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1074\/jbc.M008157200","volume":"276","author":"S Hoegy","year":"2001","unstructured":"Hoegy, S., Oh, H.-R., Corcoran, M. & Stetler-Stevenson, W. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition. J. Biol. Chem. 276, 3203\u20133214 (2001).","journal-title":"J. Biol. Chem."},{"key":"BF35077241_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z","volume":"72","author":"P Andreasen","year":"1997","unstructured":"Andreasen, P., Kioller, L., Christensen, L. & Duffy, M. The urokinase type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1\u201322 (1997).","journal-title":"Int. J. Cancer"},{"key":"BF35077241_CR28","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1038\/35046654","volume":"2","author":"S Fashena","year":"2000","unstructured":"Fashena, S. & Thomas, S. M. Signaling by adhesion receptors. Nature Cell Biol. 2, E225\u2013E229 (2000).","journal-title":"Nature Cell Biol."},{"key":"BF35077241_CR29","doi-asserted-by":"publisher","first-page":"E182","DOI":"10.1038\/35036433","volume":"2","author":"V Braga","year":"2000","unstructured":"Braga, V. The crossroads between cell-cell adhesion and motility. Nature Cell Biol. 2, E182\u2013E184 (2000).","journal-title":"Nature Cell Biol."},{"key":"BF35077241_CR30","doi-asserted-by":"publisher","first-page":"8806","DOI":"10.1074\/jbc.275.12.8806","volume":"275","author":"M Jo","year":"2000","unstructured":"Jo, M. et al. Cross talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J. Biol. Chem. 275, 8806\u20138811 (2000).","journal-title":"J. Biol. Chem."},{"key":"BF35077241_CR31","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0955-0674(96)80115-3","volume":"8","author":"JA Varner","year":"1996","unstructured":"Varner, J. A. & Cheresh, D. A. Integrins and cancer. Curr. Opin. Cell Biol. 8, 724\u2013730 (1996).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BF35077241_CR32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ki.1992.81","volume":"41","author":"AB Roberts","year":"1992","unstructured":"Roberts, A. B., McCune, B. K. & Sporn, M. B. TGF-\u03b2: regulation of extracellular matrix. Kidney Int. 41, 557\u2013559 (1992).","journal-title":"Kidney Int."},{"key":"BF35077241_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/15419069509081020","volume":"3","author":"JA Varner","year":"1995","unstructured":"Varner, J. A., Brooks, P. C. & Cheresh, D. A. The integrin \u03b1v\u03b23: angiogenesis and apoptosis. Cell Adhes. Comm. 3, 367\u2013374 (1995).","journal-title":"Cell Adhes. Comm."},{"key":"BF35077241_CR34","doi-asserted-by":"publisher","first-page":"11453","DOI":"10.1021\/bi00036a018","volume":"34","author":"F Fukai","year":"1995","unstructured":"Fukai, F. et al. Release of biologically activities from quiescent fibronectin by conformational change and limited proteolysis by matrix metalloproteinases. Biochemistry 34, 11453\u201311459 (1995).","journal-title":"Biochemistry"},{"key":"BF35077241_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/0006-291X(92)91834-D","volume":"182","author":"GE Davis","year":"1992","unstructured":"Davis, G. E. Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem. Biophys. Res. Commun. 182, 1025\u20131031 (1992).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF35077241_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"A Zlotnik","year":"2000","unstructured":"Zlotnik, A. & Yoshie, O. Chemokines: a new classification system and their role in immunity. Immunity 12, 121\u2013127 (2000).","journal-title":"Immunity"},{"key":"BF35077241_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50\u201356 (2001).","journal-title":"Nature"},{"key":"BF35077241_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1083\/jcb.134.3.793","volume":"134","author":"SM Frisch","year":"1996","unstructured":"Frisch, S. M., Vuori, K., Ruoslahti, E. & Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793\u2013799 (1996).","journal-title":"J. Cell Biol."},{"key":"BF35077241_CR39","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0955-0674(97)80124-X","volume":"9","author":"SM Frisch","year":"1997","unstructured":"Frisch, S. M. & Ruoslahti, E. Integrins and anoikis. Curr. Opin. Cell Biol. 9, 701\u2013706 (1997).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BF35077241_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0955-0674(00)00187-3","volume":"13","author":"L Cantley","year":"2001","unstructured":"Cantley, L. & Pawson, T. Cell regulation. Curr. Opin. Cell Biol. 13, 121\u2013124 (2001).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BF35077241_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/377539a0","volume":"377","author":"I Dusko","year":"1995","unstructured":"Dusko, I. et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539\u2013544 (1995).","journal-title":"Nature"},{"key":"BF35077241_CR42","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1074\/jbc.275.12.8817","volume":"275","author":"L Xue","year":"2000","unstructured":"Xue, L., Murray, J. H. & Tolkovsky, A. M. The Ras\/phosphatidylinositol 3-kinase and Ras\/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons. J. Biol. Chem. 275, 8817\u20138824 (2000).","journal-title":"J. Biol. Chem."},{"key":"BF35077241_CR43","doi-asserted-by":"publisher","first-page":"25777","DOI":"10.1074\/jbc.273.40.25777","volume":"273","author":"H Chen","year":"1998","unstructured":"Chen, H., Chan, P., Tang, M., Cheng, C. & Chang, T. Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J. Biol. Chem. 273, 25777\u201325782 (1998).","journal-title":"J. Biol. Chem."},{"key":"BF35077241_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1083\/jcb.150.4.797","volume":"150","author":"G Totsukawa","year":"2000","unstructured":"Totsukawa, G. et al. Distinct roles of ROCK and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J. Cell Biol. 150, 797\u2013806 (2000).","journal-title":"J. Cell Biol."},{"key":"BF35077241_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/35049567","volume":"1","author":"LA Liotta","year":"2000","unstructured":"Liotta, L. A. & Petricoin, E. F. Molecular profiling of human cancer. Nature Genet. Rev. 1, 48\u201356 (2000).","journal-title":"Nature Genet. Rev."},{"key":"BF35077241_CR46","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/science.289.5482.1197","volume":"289","author":"B St. Croix","year":"2000","unstructured":"St. Croix, B. et al. Genes expressed in human tumor endothelium. Science 289, 1197\u20131202 (2000).","journal-title":"Science"},{"key":"BF35077241_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/sj.onc.1204265","volume":"20","author":"CP Paweletz","year":"2001","unstructured":"Paweletz, C. P. et al. Reverse phase protein microarrays which capture disease progression shown activation of pro-survival pathways at the cancer invasion front. Oncogene 20, 1981\u20131989 (2001).","journal-title":"Oncogene"},{"key":"BF35077241_CR48","first-page":"3056","volume":"6","author":"JC Gutheil","year":"2000","unstructured":"Gutheil, J. C. et al. Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin \u03b1v\u03b23 . Clin. Cancer Res. 6, 3056\u20133061 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BF35077241_CR49","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1073\/pnas.92.5.1307","volume":"92","author":"EC Kohn","year":"1995","unstructured":"Kohn, E. C. et al. Angiogenesis: role of calcium-mediated signal transduction. Proc. Natl Acad. Sci. USA 92, 1307\u20131311 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35077241_CR50","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1242\/jcs.112.19.3205","volume":"112","author":"L Masiero","year":"1999","unstructured":"Masiero, L., Lapidos, K. A., Ambudkar, I. & Kohn, E. C. Regulation of the RhoA pathway in human endothelial cell spreading on type IV collagen: role of calcium influx. J. Cell. Sci. 112, 3205\u20133213 (1999).","journal-title":"J. Cell. Sci."},{"key":"BF35077241_CR51","first-page":"949","volume":"6","author":"MJ Weyant","year":"2000","unstructured":"Weyant, M. J., Carothers, A. M., Bertangnolli, M. E. & Bertagnolli, M. M. Colon cancer chemopreventative drugs modulate integrin-mediated signaling pathways. Clin. Cancer Res. 6, 949\u2013956 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BF35077241_CR52","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/oxfordjournals.annonc.a059091","volume":"6","author":"PD Brown","year":"1995","unstructured":"Brown, P. D. & Giavazzi, R. Matrix metalloproteinase inhibition: a review of anti-tumour activity. Annals Oncol. 6, 967\u2013974 (1995).","journal-title":"Annals Oncol."},{"key":"BF35077241_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1200\/JCO.2000.18.1.178","volume":"18","author":"E Rowinsky","year":"2000","unstructured":"Rowinsky, E. et al. Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies. J. Clin. Oncol. 18, 178\u2013186 (2000).","journal-title":"J. Clin. Oncol."},{"key":"BF35077241_CR54","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1172\/JCI118227","volume":"96","author":"PC Brooks","year":"1995","unstructured":"Brooks, P. C. et al. Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815\u20131822 (1995).","journal-title":"J. Clin. Invest."},{"key":"BF35077241_CR55","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0306-4522(00)00429-2","volume":"101","author":"E Bonfoco","year":"2000","unstructured":"Bonfoco, E., Chen, W., Paul, R., Cheresh, D. A. & Cooper, N. R. \u03b21 integrin antagonism on adherent, differentiated human neuroblastoma cells triggers an apoptotic signaling pathway. Neuroscience 101, 1145\u20131152 (2000).","journal-title":"Neuroscience"},{"key":"BF35077241_CR56","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1073\/pnas.96.4.1591","volume":"96","author":"HN Lode","year":"1999","unstructured":"Lode, H. N. et al. Synergy between an antiangiogenic integrin \u03b1v antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases. Proc. Natl Acad. Sci. USA 96, 1591\u20131596 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF35077241_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.1999.tb09404.x","volume":"886","author":"NE Kohl","year":"1999","unstructured":"Kohl, N. E. Farnesyltransferase inhibitors. Preclinical development. Ann. NY Acad. Sci. 886, 91\u2013102 (1999).","journal-title":"Ann. NY Acad. Sci."},{"key":"BF35077241_CR58","first-page":"2784","volume":"58","author":"AK Sills","year":"1998","unstructured":"Sills, A. K. et al. Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res. 58, 2784\u20132792 (1998).","journal-title":"Cancer Res."},{"key":"BF35077241_CR59","unstructured":"Kohn, E. C. et al. A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination, and demonstration of pharmacokinetic interaction. Clin. Cancer Res. (in the press)."},{"key":"BF35077241_CR60","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1038\/sj.onc.1203598","volume":"19","author":"ZQ Yuan","year":"2000","unstructured":"Yuan, Z. Q. et al. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase\/Akt pathway in human ovarian cancer. Oncogene 19, 2324\u20132330 (2000).","journal-title":"Oncogene"},{"key":"BF35077241_CR61","first-page":"257","volume":"5","author":"P Perrotte","year":"1999","unstructured":"Perrotte, P. et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin. Cancer Res. 5, 257\u2013265 (1999).","journal-title":"Clin. Cancer Res."},{"key":"BF35077241_CR62","first-page":"367","volume":"291","author":"S Iyer","year":"1999","unstructured":"Iyer, S., Gurujeyalakshimi, G. & Giri, S. N. Effects of pirfenidone on transforming growth factor-\u03b2 gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Therapeut. 291, 367\u2013373 (1999).","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"BF35077241_CR63","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","volume":"905","author":"X Fang","year":"2000","unstructured":"Fang, X. et al. Lysophospholipid growth factors in the initiation, progression, metastases and management of ovarian cancer. Ann. NY Acad. Sci. 905, 188\u2013208 (2000).","journal-title":"Ann. NY Acad. Sci."},{"key":"BF35077241_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/5042","volume":"21","author":"L Shayesteh","year":"1999","unstructured":"Shayesteh, L. et al. PIK3CA is implicated as an oncogene in ovarian cancer. Nature Genet. 21, 99\u2013102 (1999).","journal-title":"Nature Genet."},{"key":"BF35077241_CR65","first-page":"430","volume":"5","author":"T Furui","year":"1999","unstructured":"Furui, T. et al. Overexpression of edg-2\/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin. Cancer Res. 5, 430\u20134318 (1999).","journal-title":"Clin. Cancer Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/35077241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35077241","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/35077241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:59:19Z","timestamp":1684288759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/35077241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":65,"journal-issue":{"issue":"6835","published-print":{"date-parts":[[2001,5,17]]}},"alternative-id":["BF35077241"],"URL":"https:\/\/doi.org\/10.1038\/35077241","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,1]]},"assertion":[{"value":"1 May 2001","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}